Oneview Healthcare PLC (ASX: $ONE) released its Appendix 4C - Quarterly Cashflow report for the quarter ending 31 March 2024 (Q1 24). The report highlights a net operating cash outflow of €2.1m, an increase of 9% compared to the prior year corresponding quarter, primarily due to higher staff costs as the Company resources the fulfilment of recent new signings and the Baxter pipeline. The Company held cash balances of €9.1m (A$15.1m) as at 31 March 2024, with zero debt.
Oneview's CEO, James Fitter, highlighted the progress made in the Baxter partnership, with the first Purchase Order received for Nicklaus Children's Hospital in Florida. The Company also signed agreements with Inova and Mercy, demonstrating its ability to deliver on growth potential. Fitter emphasized the three key growth drivers for 2024 and acknowledged the complexity of enterprise contracts in healthcare. The Company remains committed to its Environmental, Social and Governance principles and continues to report progress on a quarterly basis.
Oneview Healthcare (ASX: $ONE) reported a net operating cash outflow of €2.1m for Q1 24, primarily driven by higher staff costs to resource recent new signings and the Baxter pipeline. The Company held cash balances of €9.1m (A$15.1m) as at 31 March 2024, with zero debt. Operational highlights included signing agreements with Inova and Mercy, and the successful launch of MyStay Mobile. The Company emphasized its commitment to Environmental, Social and Governance principles and highlighted the complexity of enterprise contracts in healthcare. Looking ahead, Oneview aims to capitalize on the renewed focus on patient experience platforms, the launch of MyStay Mobile, and the Baxter partnership to drive growth in 2024.